申请人:Xian Ming
公开号:US20130253051A1
公开(公告)日:2013-09-26
Agents of formula: where R1 and R2 vary independently and are acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, arylalkyl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocycle, or heteroatoms; and R3 is H or a member of a ring structure which includes R2, are provided; as are agents of formula: where R1, R2 and R3 vary independently and: R1=OH, OR′, NHR′, NR′R″ (with R′ R″=alkyl, aryl, heteroaryl, etc); R
2
=acyl, alkyl, aryl, sulfonyl, etc; R3=alkyl, aryl, substituted aryl, heteroaryl, etc; and R4 and R5 are (independently) H, methyl or alkyl, substituted alkyl, aryl, substituted aryl, etc. Methods of using the agents to treat e.g. cardiovascular disease, stroke, shock, injuries caused by hypoxia, male erectile dysfunction, and Alzheimer's are provided.
提供了公式代理人:其中R1和R2分别变化且独立,并且为酰基,磺酰基,磷酰基,烷基,取代烷基,卤素,芳基,芳基烷基,取代芳基,杂环芳基,烯基,取代烯基,炔基,取代炔基,环烷基,杂环,或杂原子; 而R3为H或包括R2的环结构的成员; 提供了公式代理人:其中R1,R2和R3独立变化且:R1 = OH,OR′,NHR′,NR′R″(其中R′ R″ = 烷基,芳基,杂环芳基等); R2 = 酰基,烷基,芳基,磺酰基等; R3 = 烷基,芳基,取代芳基,杂环芳基等; 而R4和R5为(独立的)H,甲基或烷基,取代烷基,芳基,取代芳基等。提供了使用这些代理人治疗心血管疾病,中风,休克,缺氧引起的损伤,男性勃起功能障碍和阿尔茨海默病的方法。